Multiple Sclerosis — Views on Physical Activity Following a Relapse in People With Multiple Sclerosis
Citation(s)
Adamson, B C., Adamson, M. D., Littlefield, M. M. and Motl, R. W. (2017) 'Move it or lose it: perceptions of the impact of physical activity on multiple sclerosis symptoms, relapse and disability identity', Qualitative Research in Sport, Exercise and Health
Asano M, Raszewski R, Finlayson M Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review. Int J MS Care. 2014 Summer;16(2):99-104. doi: 10.7224/1537-2073.2013-031.
Caspersen CJ, Powell KE, Christenson GM Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985 Mar-Apr;100(2):126-31.
Compston A, Coles A Multiple sclerosis. Lancet. 2008 Oct 25;372(9648):1502-17. doi: 10.1016/S0140-6736(08)61620-7.
Craig J, Young CA, Ennis M, Baker G, Boggild M A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1225-30.
Hirst CL, Ingram G, Pickersgill TP, Robertson NP Temporal evolution of remission following multiple sclerosis relapse and predictors of outcome. Mult Scler. 2012 Aug;18(8):1152-8. doi: 10.1177/1352458511433919. Epub 2012 Jan 4.
Kjølhede T, Vissing K, Dalgas U Multiple sclerosis and progressive resistance training: a systematic review. Mult Scler. 2012 Sep;18(9):1215-28. doi: 10.1177/1352458512437418. Epub 2012 Apr 24. Review.
Learmonth YC, Motl RW Physical activity and exercise training in multiple sclerosis: a review and content analysis of qualitative research identifying perceived determinants and consequences. Disabil Rehabil. 2016;38(13):1227-42. doi: 10.3109/09638288.2015.1077397. Epub 2015 Aug 28. Review.
Mackenzie IS, Morant SV, Bloomfield GA, MacDonald TM, O'Riordan J Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database. J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):76-84. doi: 10.1136/jnnp-2013-305450. Epub 2013 Sep 19.
Motl RW, Learmonth YC, Pilutti LA, Gappmaier E, Coote S Top 10 research questions related to physical activity and multiple sclerosis. Res Q Exerc Sport. 2015 Jun;86(2):117-29. doi: 10.1080/02701367.2015.1023099. Epub 2015 Apr 15.
Motl RW, McAuley E, Snook EM Physical activity and multiple sclerosis: a meta-analysis. Mult Scler. 2005 Aug;11(4):459-63.
MS Society (2017) MS Society Forum [Online] Available at: https://community.mssociety.org.uk/forums/everyday-living/physical-activity-or-exercise-after-relapse#comment (Accessed 10 April 2018).
Pilutti LA, Platta ME, Motl RW, Latimer-Cheung AE The safety of exercise training in multiple sclerosis: a systematic review. J Neurol Sci. 2014 Aug 15;343(1-2):3-7. doi: 10.1016/j.jns.2014.05.016. Epub 2014 May 15. Review.
Platta ME, Ensari I, Motl RW, Pilutti LA Effect of Exercise Training on Fitness in Multiple Sclerosis: A Meta-Analysis. Arch Phys Med Rehabil. 2016 Sep;97(9):1564-1572. doi: 10.1016/j.apmr.2016.01.023. Epub 2016 Feb 16. Review.
Wilkinson, H R. and das Nair, R. (2013), 'The psychological impact of the unpredictability of multiple sclerosis: a qualitative literature meta-synthesis', British Journal of Neuroscience Nursing, 9 (4), pp. 172-178
Attitudes, Barriers and Facilitators to Physical Activity in People With Multiple Sclerosis Following a Relapse
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.